Growth inhibition induced by antiprogestins RU - 38486, ORG - 31710, and CDB - 2914 in ovarian
cancer cells involves inhibition of cyclin dependent kinase 2.
Not exact matches
Basically, CAR - T therapy
involves taking a patient's own immune «killer» T -
cells, inserting new genetic code into those
cells which turn them into
cancer - hunters that can home in on malignant B -
cells (another kind of immune
cell), and then pumping these specialized leukemia - busting
cells back into the patient.
Cancer - focused CRISPR technology
involves taking a set of molecular shears and the guiding molecule Cas9 in order to cut out unwanted genes in immune
cells that may help proliferate
cancers.
In clinical trials the treatment — which
involves extracting individual patients» immune T -
cells, modifying them to seek out tell - tale biological markers associated with blood
cancers like aggressive lymphoma, and then pumping those modified killer
cells back into the body — has shown major promise, in some cases eliminating all signs of the
cancer in patients six months after treatment.
Those two companies, along with their larger competitor Novartis (nvs), are developing experimental chimeric antigen receptor T -
cell (CAR - T) technology platforms, which are highly personalized treatments that
involve extracting patients» immune
cells, re-engineering them to target their specific
cancers, and then pumping these sniper -
cells back into the body.
The novel treatment space
involves transforming a patient's own immune T -
cells into
cancer - busting weapons.
Bellicum is among the flurry of biotechs investing heavily into
cell therapies such as experimental chimeric antigen receptor T -
cell (CAR - T) treatments for
cancer (this is the next - gen treatment that
involves reprogramming immune
cells to become
cancer killers and has shown promise in blood
cancers, which Bellicum specializes in).
It's the second approval for this pioneering approach to
cancer treatment, which
involves re-engineering patients» own immune
cells to become
cancer killers, after the FDA's approval of Novartis» Kymriah in August.
Overcoming the immense logistical challenges
involved with withdrawing, shipping, modifying, returning, then reinfusing
cells for every patient treated paints a scary question mark on the future of
cell - based
cancer therapies.
CAR - T approaches
involve reengineering T -
cells to find and destroy
cancer cells, but that process can cause cytokine release syndrome (CRS), a life - threatening immune response NantKwest hopes to sidestep.
Metastasis
involves clumps of
cancer cells becoming detached and moving through the blood stream or the lymphatic system to other areas, where they become attached to a new site and continue growing.
Cancer: Flaxseed may protect against breast cancer, prostate cancer, and colon cancer by inhibiting tumor growth and blocking enzymes that are involved in the spread of tumor
Cancer: Flaxseed may protect against breast
cancer, prostate cancer, and colon cancer by inhibiting tumor growth and blocking enzymes that are involved in the spread of tumor
cancer, prostate
cancer, and colon cancer by inhibiting tumor growth and blocking enzymes that are involved in the spread of tumor
cancer, and colon
cancer by inhibiting tumor growth and blocking enzymes that are involved in the spread of tumor
cancer by inhibiting tumor growth and blocking enzymes that are
involved in the spread of tumor
cells.
Treatment typically
involves chemotherapy (using chemicals intravenously to kill
cancer cells), radiation therapy (using high - powered X-rays to kill
cancer cells), or surgery to remove the breast and surrounding lymph nodes.
She demonstrated that early experience leads to lasting changes in the molecular structure of the brain and discovered a gene
involved in the spread of brain
cancer cells into healthy brain tissue.
Non — small
cell lung
cancer may
involve genetic aberrations that can be used to direct therapy.
Lewis is now skimming through these genes to check their function; of those he's looked at so far, several are
involved in growth and development,
cell differentiation,
cell death, and protecting against
cancer.
The team led by Andreas Plückthun, Director of the Department of Biochemistry at the University of Zurich,
involving postdoc Rastik Tamaskovic and PhD student Martin Schwill, has now found out why these antibodies merely slow tumor growth rather than killing off the
cancer cells.
A «Trojan horse» treatment for an aggressive form of brain
cancer, which
involves using tiny nanoparticles of gold to kill tumour
cells, has been successfully tested by scientists.
Several studies have supported a role for
cancer stem
cells in the aggressive brain tumors called glioblastoma, but those studies
involved inducing human tumors to grow in mice, and as such their relevance to
cancer in humans has been questioned.
Moreno also found a homologue of a human
cancer gene
involved in
cell competition.
Non-melanoma skin
cancers — specifically, basal
cell carcinoma and squamous
cell carcinoma — are more likely than melanoma to
involve itch or pain, the study found.
Therefore, a novel therapeutic approach in inflammatory breast
cancer could
involve a combination of conventional chemotherapy with small - molecule inhibitors of the Cdk2
cell cycle kinase.
«Our work suggests a mechanism for
cell lethality
involving the regulation of BCAAs as crucial elements in pancreatic
cancer by regulating ME3,» said Ronald DePinho, M.D., professor of Cancer Biology, senior author of the Nature paper and president of MD And
cancer by regulating ME3,» said Ronald DePinho, M.D., professor of
Cancer Biology, senior author of the Nature paper and president of MD And
Cancer Biology, senior author of the Nature paper and president of MD Anderson.
The theory that
cancer progression
involves the acquisition by tumor
cells of features similar to those of stem
cells has gained strength in the scientific community.
These progenitor
cells are often drug resistant and can initiate
cancer development and are possibly
involved in
cancer relapse.
A team from the Spanish National
Cancer Research Centre (CNIO) has determined for the first time the high - resolution structure of a complex (R2TP) involved in key processes for cell survival and in diseases such as c
Cancer Research Centre (CNIO) has determined for the first time the high - resolution structure of a complex (R2TP)
involved in key processes for
cell survival and in diseases such as
cancercancer.
By providing a woman's family history of these
cancers, including the ages they were diagnosed, the programs calculate a probability that the patient carries a harmful mutation in BRCA1 or BRCA2 (genes
involved in controlling malignant
cell growth).
If a breast
cancer line had silently contaminated Klonisch's
cell culture early on, it would have been subject to the usual technique for immortalizing a normal
cell (which
involves applying enzymes, antibiotics and antibiotic - resistant genes).
But Pearse had shown that no virus was
involved; the
cancer cells had transferred directly from one animal to the next.
Óscar Llorca and his team have used this technique to learn about the structure and functioning of a complex system called R2TP, which is
involved in various key processes for
cell survival such as the activation of the kinases mTOR, ATR and ATM, proteins that are the target of various
cancer drugs currently being developed.
Plakoglobin is a component of two important structures
involved in
cell - to -
cell adhesion, and the investigators found that suppressing its expression caused CTC clusters to fall apart, reducing their metastatic potential, and also disrupted
cell - to -
cell contact between breast
cancer cells but not normal breast tissue.
To see whether
cancer stem
cell renewal
involves a chain of events similar to that used by embryonic stem
cells, and whether the process was affected by oxygen levels, Semenza and graduate student Chuanzhao Zhang focused their studies on two human breast
cancer cell lines that responded to low oxygen by ramping up production of the protein ALKBH5, which removes methyl groups from mRNAs.
The study
involved 23 patients with relapsed or treatment - resistant HL, a
cancer of white blood
cells called lymphocytes.
Finding out
involves passing a sample of blood through a microfluidic device, in whose tiny channels
cancer cells can be captured and identified.
The IFNGR receptor is one of these membrane proteins and undertakes to activate genes
involved in a huge variety of
cell processes, including defence against pathogens and
cancer.
Many genes that are
involved in the growth and development of embryos or adult stem
cells also play roles in
cancer, Resar adds.
The researchers also want to see what other proteins and mRNAs are
involved in the relationship, and why some
cancer cell lines they tested did not show the same increased ALKBH5 levels in response to low oxygen levels.
In earlier studies
involving animal models and human
cancer cell lines, researchers found that breast
cancer spreads when three specific
cells are in direct contact: an endothelial
cell (a type of
cell that lines the blood vessels), a perivascular macrophage (a type of immune
cell found near blood vessels), and a tumor
cell that produces high levels of Mena, a protein that enhances a
cancer cell's ability to spread.
This complex is
involved in regulating the
cell replication cycle, which becomes dysregulated in
cancer.
Diagnosing
cancer today usually
involves various imaging techniques, examining tissue samples under a microscope, or testing
cells for proteins or genetic material.
Such
cell - tracing techniques are the right approach to test the
cancer stem
cell model, says Sean Morrison, who studies stem
cells and
cancer at UTSMC and who was not
involved in any of the studies.
The current research
involved acute lymphoblastic leukemia (ALL)
cells, a common type of childhood
cancer.
Studying breast and brain
cancer cells in a hypoxia incubator, Uniacke and his team discovered that cadherin - 22 is
involved in this process to enable the spread of
cancer cells.
«The research, which
involved one of the most common childhood
cancers, shows that the
cancer cells were eliminated.
The research suggests that reducing production of the protein, called myoferlin, affects
cancer cells in two primary ways: by changing the activation of many genes
involved in metastasis in favor of normal
cell behavior, and by altering mechanical properties of
cancer cells — including their shape and ability to invade — so they are more likely to remain nested together rather than breaking away to travel to other tissues.
New results from a clinical trial
involving more than 900 military veterans at high risk for keratinocyte carcinoma skin
cancer provides evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of a squamous
cell carcinoma (SCC) needing surgery by 75 percent within a year.
The team is now working with doctors at Massachusetts General Hospital, who hope to use the new, noninvasive technique to study
cells involved in
cancer, asthma, and other conditions in which
cell properties change as a disease progresses.
A similar idea
involves injecting
cancer patients with strains of different bacteria that have been genetically modified to present antigens found on pancreatic
cancer cells.
Because AML is difficult to treat, standard treatment commonly
involves multiple chemotherapy medicines that are given at a higher dose in order to kill the
cancer cells.
The laboratory of Marcos Malumbres, who is head of the Spanish National
Cancer Research Centre's (CNIO)
Cell Division & Cancer Group, working alongside Isabel Fariñas» team from the University of Valencia, shows, in a study published today in the journal Nature Communications, how in mice the elimination of the Cdh1 protein — a sub-unit of the APC / C complex, involved in the control of cell division — prevents cellular proliferation of rapidly dividing ce
Cell Division &
Cancer Group, working alongside Isabel Fariñas» team from the University of Valencia, shows, in a study published today in the journal Nature Communications, how in mice the elimination of the Cdh1 protein — a sub-unit of the APC / C complex,
involved in the control of
cell division — prevents cellular proliferation of rapidly dividing ce
cell division — prevents cellular proliferation of rapidly dividing
cells.